Curasight
Curasight to present at Redeye Fight Cancer Seminar
REG
The presentation will include an update on the momentum and business progress made by the company and look ahead at the coming news flow for the new year. Management will give an overall update on the company's pipeline based on the proprietary uPAR theranostics platform and focused on diagnosing and treating brain and prostate cancer.
The presentation will be webcasted live 15:05-15:25 (CET), Thursday January 19, 2023.
For more information - please click here
| Datum | 2023-01-16, kl 11:03 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!